1
|
Yeo RX, Dijkstra PJ, De Carvalho FG, Yi F, Pino MF, Smith SR, Sparks LM. Aerobic training increases mitochondrial respiratory capacity in human skeletal muscle stem cells from sedentary individuals. Am J Physiol Cell Physiol 2022; 323:C606-C616. [PMID: 35785986 DOI: 10.1152/ajpcell.00146.2022] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
The impact of aerobic training on human skeletal muscle cell (HSkMC) mitochondrial metabolism is a significant research gap, critical to understanding the mechanisms by which exercise augments skeletal muscle metabolism. We therefore assessed mitochondrial content and capacity in fully differentiated CD56+ HSkMCs from lean active (LA) and sedentary individuals with obesity (OS) at baseline, as well as lean/overweight sedentary individuals (LOS) at baseline and following an 18-day aerobic training intervention. Participants had in vivo skeletal muscle PCr recovery rate by 31P-MRS (mitochondrial oxidative kinetics) and cardiorespiratory fitness (VO2max) assessed at baseline. Biopsies of the vastus lateralis were performed for the isolation of skeletal muscle stem cells. LOS individuals repeated all assessments post-training. HSkMCs were evaluated for mitochondrial respiratory capacity by high resolution respirometry. Data were normalized to two indices of mitochondrial content (CS activity and OXPHOS protein expression) and a marker of total cell count (quantity of DNA).LA individuals had significantly higher VO2max than OS and LOS-Pre training; however, no differences were observed in skeletal muscle mitochondrial capacity, nor in carbohydrate- or fatty acid-supported HSkMC respiratory capacity. Aerobic training robustly increased in vivo skeletal muscle mitochondrial capacity of LOS individuals, as well as carbohydrate-supported HSkMC respiratory capacity. Indices of mitochondrial content and total cell count were similar among the groups and did not change with aerobic training.Our findings demonstrate that bioenergetic changes induced with aerobic training in skeletal muscle in vivo are retained in HSkMCs in vitro without impacting mitochondrial content, suggesting that training improves intrinsic skeletal muscle mitochondrial capacity.
Collapse
Affiliation(s)
- Reichelle X Yeo
- AdventHealth Translational Research Institute, Orlando, FL, United States
| | - Pieter J Dijkstra
- AdventHealth Translational Research Institute, Orlando, FL, United States
| | | | - Fanchao Yi
- AdventHealth Translational Research Institute, Orlando, FL, United States
| | - Maria F Pino
- AdventHealth Translational Research Institute, Orlando, FL, United States
| | - Steven R Smith
- AdventHealth Translational Research Institute, Orlando, FL, United States
| | - Lauren M Sparks
- AdventHealth Translational Research Institute, Orlando, FL, United States
| |
Collapse
|
2
|
Takagi H, Ikehara T, Hashimoto K, Tanimoto K, Shimazaki A, Kashiwagi Y, Sakamoto S, Yukioka H. Acetyl-CoA carboxylase 2 inhibition reduces skeletal muscle bioactive lipid content and attenuates progression of type 2 diabetes in Zucker diabetic fatty rats. Eur J Pharmacol 2021; 910:174451. [PMID: 34454928 DOI: 10.1016/j.ejphar.2021.174451] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/08/2021] [Revised: 08/25/2021] [Accepted: 08/25/2021] [Indexed: 11/17/2022]
Abstract
Intramyocellular lipid (IMCL) accumulation in skeletal muscle is closely associated with development of insulin resistance. In particular, diacylglycerol and ceramide are currently considered as causal bioactive lipids for impaired insulin action. Recently, inhibition of acetyl-CoA carboxylase 2 (ACC2), which negatively modulates mitochondrial fatty acid oxidation, has been shown to reduce total IMCL content and improve whole-body insulin resistance. This study aimed to investigate whether ACC2 inhibition-induced compositional changes in bioactive lipids, especially diacylglycerol and ceramide, within skeletal muscle contribute to the improved insulin resistance. In skeletal muscle of normal rats, treatment of the ACC2 inhibitor compound 2e significantly decreased both diacylglycerol and ceramide levels while having no significant impact on other lipid metabolite levels. In skeletal muscle of Zucker diabetic fatty (ZDF) rats, which exhibited greater lipid accumulation than that of normal rats, compound 2e significantly decreased diacylglycerol and ceramide levels corresponding to reduced long chain acyl-CoA pools. Additionally, in the lipid metabolomics study, ZDF rats treated with compound 2e also showed improved diabetes-related metabolic disturbance, as reflected by delayed hyperinsulinemia as well as upregulated gene expression associated with diabetic conditions in skeletal muscle. These metabolic improvements were strongly correlated with the bioactive lipid reductions. Furthermore, long-term treatment of compound 2e markedly improved whole-body insulin resistance, attenuated hyperglycemia and delayed insulin secretion defect even at severe diabetic conditions. These findings suggest that ACC2 inhibition decreases diacylglycerol and ceramide accumulation within skeletal muscle by enhancing acyl-CoA breakdown, leading to attenuation of lipid-induced insulin resistance and subsequent diabetes progression.
Collapse
Affiliation(s)
- Hiroyuki Takagi
- Shionogi Pharmaceutical Research Center, Shionogi & Co., Ltd., 3-1-1, Futaba-cho, Toyonaka, Osaka, 561-0825, Japan.
| | - Tatsuya Ikehara
- Shionogi Pharmaceutical Research Center, Shionogi & Co., Ltd., 3-1-1, Futaba-cho, Toyonaka, Osaka, 561-0825, Japan
| | - Kumi Hashimoto
- Shionogi Pharmaceutical Research Center, Shionogi & Co., Ltd., 3-1-1, Futaba-cho, Toyonaka, Osaka, 561-0825, Japan
| | - Keiichi Tanimoto
- Shionogi Pharmaceutical Research Center, Shionogi & Co., Ltd., 3-1-1, Futaba-cho, Toyonaka, Osaka, 561-0825, Japan
| | - Atsuyuki Shimazaki
- Shionogi Pharmaceutical Research Center, Shionogi & Co., Ltd., 3-1-1, Futaba-cho, Toyonaka, Osaka, 561-0825, Japan
| | - Yuto Kashiwagi
- Shionogi Pharmaceutical Research Center, Shionogi & Co., Ltd., 3-1-1, Futaba-cho, Toyonaka, Osaka, 561-0825, Japan
| | - Shingo Sakamoto
- Shionogi Pharmaceutical Research Center, Shionogi & Co., Ltd., 3-1-1, Futaba-cho, Toyonaka, Osaka, 561-0825, Japan
| | - Hideo Yukioka
- Shionogi Pharmaceutical Research Center, Shionogi & Co., Ltd., 3-1-1, Futaba-cho, Toyonaka, Osaka, 561-0825, Japan
| |
Collapse
|
3
|
González Hernández MA, Blaak EE, Hoebers NTH, Essers YPG, Canfora EE, Jocken JWE. Acetate Does Not Affect Palmitate Oxidation and AMPK Phosphorylation in Human Primary Skeletal Muscle Cells. Front Endocrinol (Lausanne) 2021; 12:659928. [PMID: 34220709 PMCID: PMC8248488 DOI: 10.3389/fendo.2021.659928] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/28/2021] [Accepted: 05/25/2021] [Indexed: 11/13/2022] Open
Abstract
Our recent in vivo human studies showed that colonic administration of sodium acetate (SA) resulted in increased circulating acetate levels, which was accompanied by increments in whole-body fat oxidation in overweight-obese men. Since skeletal muscle has a major role in whole-body fat oxidation, we aimed to investigate effects of SA on fat oxidation and underlying mechanisms in human primary skeletal muscle cells (HSkMC). We investigated the dose (0-5 mmol/L) and time (1, 4, 20, and 24 h) effect of SA on complete and incomplete endogenous and exogenous oxidation of 14C-labeled palmitate in HSkMC derived from a lean insulin sensitive male donor. Both physiological (0.1 and 0.25 mmol/L) and supraphysiological (0.5, 1 and 5 mmol/L) concentrations of SA neither increased endogenous nor exogenous fat oxidation over time in HSkMC. In addition, no effect of SA was observed on Thr172-AMPKα phosphorylation. In conclusion, our previously observed in vivo effects of SA on whole-body fat oxidation in men may not be explained via direct effects on HSkMC fat oxidation. Nevertheless, SA-mediated effects on whole-body fat oxidation may be triggered by other mechanisms including gut-derived hormones or may occur in other metabolically active tissues.
Collapse
|
4
|
Nemec M, Vernerová L, Laiferová N, Balážová M, Vokurková M, Kurdiová T, Oreská S, Kubínová K, Klein M, Špiritović M, Tomčík M, Vencovský J, Ukropec J, Ukropcová B. Altered dynamics of lipid metabolism in muscle cells from patients with idiopathic inflammatory myopathy is ameliorated by 6 months of training. J Physiol 2020; 599:207-229. [PMID: 33063873 DOI: 10.1113/jp280468] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/08/2020] [Accepted: 10/13/2020] [Indexed: 12/17/2022] Open
Abstract
KEY POINTS Regular exercise improves muscle functional capacity and clinical state of patients with idiopathic inflammatory myopathy (IIM). In our study, we used an in vitro model of human primary muscle cell cultures, derived from IIM patients before and after a 6-month intensive supervised training intervention to assess the impact of disease and exercise on lipid metabolism dynamics. We provide evidence that muscle cells from IIM patients display altered dynamics of lipid metabolism and impaired adaptive response to saturated fatty acid load compared to healthy controls. A 6-month intensive supervised exercise training intervention in patients with IIM mitigated disease effects in their cultured muscle cells, improving or normalizing their capacity to handle lipids. These findings highlight the putative role of intrinsic metabolic defects of skeletal muscle in the pathogenesis of IIM and the positive impact of exercise, maintained in vitro by yet unknown epigenetic mechanisms. ABSTRACT Exercise improves skeletal muscle function, clinical state and quality of life in patients with idiopathic inflammatory myopathy (IIM). Our aim was to identify disease-related metabolic perturbations and the impact of exercise in skeletal muscle cells of IIM patients. Patients underwent a 6-month intensive supervised training intervention. Muscle function, anthropometric and metabolic parameters were examined and muscle cell cultures were established (m. vastus lateralis; Bergström needle biopsy) before and after training from patients and sedentary age/sex/body mass index-matched controls. [14 C]Palmitate was used to determine fat oxidation and lipid synthesis (thin layer chromatography). Cells were exposed to a chronic (3 days) and acute (3 h) metabolic challenge (the saturated fatty acid palmitate, 100 μm). Reduced oxidative (intermediate metabolites, -49%, P = 0.034) and non-oxidative (diglycerides, -38%, P = 0.013) lipid metabolism was identified in palmitate-treated muscle cells from IIM patients compared to controls. Three days of palmitate exposure elicited distinct regulation of oxidative phosphorylation (OxPHOS) complex IV and complex V/ATP synthase (P = 0.012/0.005) and adipose triglyceride lipase in patients compared to controls (P = 0.045) (immunoblotting). Importantly, 6 months of training in IIM patients improved lipid metabolism (CO2 , P = 0.010; intermediate metabolites, P = 0.041) and activation of AMP kinase (P = 0.007), and nearly normalized palmitate-induced changes in OxPHOS proteins in myotubes from IIM patients, in parallel with improvements of patients' clinical state. Myotubes from IIM patients displayed altered dynamics of lipid metabolism and impaired response to metabolic challenge with saturated fatty acid. Our observations suggest that metabolic defects intrinsic to skeletal muscle could represent non-immune pathomechanisms, which can contribute to muscle weakness in IIM. A 6-month training intervention mitigated disease effects in muscle cells in vitro, indicating the existence of epigenetic regulatory mechanisms.
Collapse
Affiliation(s)
- M Nemec
- Biomedical Research Centre, Slovak Academy of Sciences, Institute of Experimental Endocrinology, Bratislava, Slovakia
| | - L Vernerová
- Institute of Rheumatology and Department of Rheumatology, First Faculty of Medicine, Charles University, Prague, Czech Republic
| | - N Laiferová
- Biomedical Research Centre, Slovak Academy of Sciences, Institute of Experimental Endocrinology, Bratislava, Slovakia.,Institute of Pathophysiology, Faculty of Medicine, Comenius University, Bratislava, Slovakia
| | - M Balážová
- Centre of Biosciences, Slovak Academy of Sciences, Bratislava, Slovakia
| | - M Vokurková
- Institute of Rheumatology and Department of Rheumatology, First Faculty of Medicine, Charles University, Prague, Czech Republic
| | - T Kurdiová
- Biomedical Research Centre, Slovak Academy of Sciences, Institute of Experimental Endocrinology, Bratislava, Slovakia
| | - S Oreská
- Institute of Rheumatology and Department of Rheumatology, First Faculty of Medicine, Charles University, Prague, Czech Republic
| | - K Kubínová
- Institute of Rheumatology and Department of Rheumatology, First Faculty of Medicine, Charles University, Prague, Czech Republic
| | - M Klein
- Institute of Rheumatology and Department of Rheumatology, First Faculty of Medicine, Charles University, Prague, Czech Republic
| | - M Špiritović
- Institute of Rheumatology and Department of Rheumatology, First Faculty of Medicine, Charles University, Prague, Czech Republic.,Department of Physiotherapy, Faculty of Physical Education and Sport, Charles University, Prague, Czech Republic
| | - M Tomčík
- Institute of Rheumatology and Department of Rheumatology, First Faculty of Medicine, Charles University, Prague, Czech Republic
| | - J Vencovský
- Institute of Rheumatology and Department of Rheumatology, First Faculty of Medicine, Charles University, Prague, Czech Republic
| | - J Ukropec
- Biomedical Research Centre, Slovak Academy of Sciences, Institute of Experimental Endocrinology, Bratislava, Slovakia
| | - B Ukropcová
- Biomedical Research Centre, Slovak Academy of Sciences, Institute of Experimental Endocrinology, Bratislava, Slovakia.,Institute of Pathophysiology, Faculty of Medicine, Comenius University, Bratislava, Slovakia
| |
Collapse
|
5
|
Overfeeding and Substrate Availability, But Not Age or BMI, Alter Human Satellite Cell Function. Nutrients 2020; 12:nu12082215. [PMID: 32722351 PMCID: PMC7468931 DOI: 10.3390/nu12082215] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/18/2020] [Revised: 07/09/2020] [Accepted: 07/21/2020] [Indexed: 12/25/2022] Open
Abstract
Satellite cells (SC) aid skeletal muscle growth and regeneration. SC-mediated skeletal muscle repair can both be influenced by and exacerbate several diseases linked to a fatty diet, obesity, and aging. The purpose of this study was to evaluate the effects of different lifestyle factors on SC function, including body mass index (BMI), age, and high-fat overfeeding. For this study, SCs were isolated from the vastus lateralis of sedentary young (18–30 years) and sedentary older (60–80 years) men with varying BMIs (18–32 kg/m2), as well as young sedentary men before and after four weeks of overfeeding (OVF) (55% fat/ + 1000 kcal, n = 4). The isolated SCs were then treated in vitro with a control (5 mM glucose, 10% fetal bovine serum (FBS)) or a high substrate growth media (HSM) (10% FBS, 25 mM glucose, and 400 μM 2:1 oleate–palmitate). Cells were assessed on their ability to proliferate, differentiate, and fuel substrate oxidation after differentiation. The effect of HSM was measured as the percentage difference between SCs exposed to HSM compared to control media. In vitro SC function was not affected by donor age. OVF reduced SC proliferation rates (–19% p < 0.05) but did not influence differentiation. Cellular proliferation in response to HSM was correlated to the donor’s body mass index (BMI) (r2 = 0.6121, p < 0.01). When exposed to HSM, SCs from normal weight (BMI 18–25 kg/m2) participants exhibited reduced proliferation and fusion rates with increased fatty-acid oxidation (p < 0.05), while SCs from participants with higher BMIs (BMI 25–32 kg/m2) demonstrated enhanced proliferation in HSM. HSM reduced proliferation and fusion (p < 0.05) in SCs isolated from subjects before OVF, whereas HSM exposure accelerated proliferation and fusion in SCs collected following OVF. These results indicated that diet has a greater influence on SC function than age and BMI. Though age and BMI do not influence in vitro SC function when grown in controlled conditions, both factors influenced the response of SCs to substrate challenges, indicating age and BMI may mediate responses to diet.
Collapse
|
6
|
Insulin Resistance in Pregnancy: Implications for Mother and Offspring. CONTEMPORARY ENDOCRINOLOGY 2020. [DOI: 10.1007/978-3-030-25057-7_5] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/12/2022]
|
7
|
Tan-Chen S, Guitton J, Bourron O, Le Stunff H, Hajduch E. Sphingolipid Metabolism and Signaling in Skeletal Muscle: From Physiology to Physiopathology. Front Endocrinol (Lausanne) 2020; 11:491. [PMID: 32849282 PMCID: PMC7426366 DOI: 10.3389/fendo.2020.00491] [Citation(s) in RCA: 32] [Impact Index Per Article: 8.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/30/2020] [Accepted: 06/22/2020] [Indexed: 12/14/2022] Open
Abstract
Sphingolipids represent one of the major classes of eukaryotic lipids. They play an essential structural role, especially in cell membranes where they also possess signaling properties and are capable of modulating multiple cell functions, such as apoptosis, cell proliferation, differentiation, and inflammation. Many sphingolipid derivatives, such as ceramide, sphingosine-1-phosphate, and ganglioside, have been shown to play many crucial roles in muscle under physiological and pathological conditions. This review will summarize our knowledge of sphingolipids and their effects on muscle fate, highlighting the role of this class of lipids in modulating muscle cell differentiation, regeneration, aging, response to insulin, and contraction. We show that modulating sphingolipid metabolism may be a novel and interesting way for preventing and/or treating several muscle-related diseases.
Collapse
Affiliation(s)
- Sophie Tan-Chen
- Centre de Recherche des Cordeliers, INSERM, Sorbonne Université, Université de Paris, Paris, France
- Institut Hospitalo-Universitaire ICAN, Paris, France
| | - Jeanne Guitton
- Université Saclay, CNRS UMR 9197, Institut des Neurosciences Paris-Saclay, Orsay, France
| | - Olivier Bourron
- Centre de Recherche des Cordeliers, INSERM, Sorbonne Université, Université de Paris, Paris, France
- Institut Hospitalo-Universitaire ICAN, Paris, France
- Assistance Publique-Hôpitaux de Paris, Département de Diabétologie et Maladies Métaboliques, Hôpital Pitié-Salpêtrière, Paris, France
| | - Hervé Le Stunff
- Université Saclay, CNRS UMR 9197, Institut des Neurosciences Paris-Saclay, Orsay, France
| | - Eric Hajduch
- Centre de Recherche des Cordeliers, INSERM, Sorbonne Université, Université de Paris, Paris, France
- Institut Hospitalo-Universitaire ICAN, Paris, France
- *Correspondence: Eric Hajduch
| |
Collapse
|
8
|
Garneau L, Aguer C. Role of myokines in the development of skeletal muscle insulin resistance and related metabolic defects in type 2 diabetes. DIABETES & METABOLISM 2019; 45:505-516. [PMID: 30844447 DOI: 10.1016/j.diabet.2019.02.006] [Citation(s) in RCA: 49] [Impact Index Per Article: 9.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/08/2018] [Revised: 02/04/2019] [Accepted: 02/25/2019] [Indexed: 12/20/2022]
Abstract
Due to its mass, skeletal muscle is the major site of glucose uptake and an important tissue in the development of type 2 diabetes (T2D). Muscles of patients with T2D are affected with insulin resistance and mitochondrial dysfunction, which result in impaired glucose and fatty acid metabolism. A well-established method of managing the muscle metabolic defects occurring in T2D is physical exercise. During exercise, muscles contract and secrete factors called myokines which can act in an autocrine/paracrine fashion to improve muscle energy metabolism. In patients with T2D, plasma levels as well as muscle levels (mRNA and protein) of some myokines are upregulated, while others are downregulated. The signalling pathways of certain myokines are also altered in skeletal muscle of patients with T2D. Taken together, these findings suggest that myokine secretion is an important factor contributing to the development of muscle metabolic defects during T2D. It is also of interest considering that lack of physical activity is closely linked to the occurrence of this disease. The causal relationships between sedentary behavior, factors secreted by skeletal muscle at rest and during contraction and the development of T2D remain to be elucidated. Many myokines shown to influence muscle energy metabolism still have not been characterized in the context of T2D in skeletal muscle specifically. The purpose of this review is to highlight what is known and what remains to be determined regarding myokine secretion in patients with T2D to uncover potential therapeutic targets for the management of this disease.
Collapse
Affiliation(s)
- L Garneau
- University of Ottawa, Faculty of Medicine, Department of Biochemistry, Microbiology and Immunology, Ottawa, ON, K1H 8M5, Canada; Institut du Savoir Montfort - recherche, Ottawa, ON, K1K 0T2, Canada
| | - C Aguer
- University of Ottawa, Faculty of Medicine, Department of Biochemistry, Microbiology and Immunology, Ottawa, ON, K1H 8M5, Canada; Institut du Savoir Montfort - recherche, Ottawa, ON, K1K 0T2, Canada.
| |
Collapse
|
9
|
Kappler L, Kollipara L, Lehmann R, Sickmann A. Investigating the Role of Mitochondria in Type 2 Diabetes - Lessons from Lipidomics and Proteomics Studies of Skeletal Muscle and Liver. ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY 2019; 1158:143-182. [PMID: 31452140 DOI: 10.1007/978-981-13-8367-0_9] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 02/07/2023]
Abstract
Mitochondrial dysfunction is discussed as a key player in the pathogenesis of type 2 diabetes mellitus (T2Dm), a highly prevalent disease rapidly developing as one of the greatest global health challenges of this century. Data however about the involvement of mitochondria, central hubs in bioenergetic processes, in the disease development are still controversial. Lipid and protein homeostasis are under intense discussion to be crucial for proper mitochondrial function. Consequently proteomics and lipidomics analyses might help to understand how molecular changes in mitochondria translate to alterations in energy transduction as observed in the healthy and metabolic diseases such as T2Dm and other related disorders. Mitochondrial lipids integrated in a tool covering proteomic and functional analyses were up to now rarely investigated, although mitochondrial lipids might provide a possible lynchpin in the understanding of type 2 diabetes development and thereby prevention. In this chapter state-of-the-art analytical strategies, pre-analytical aspects, potential pitfalls as well as current proteomics and lipidomics-based knowledge about the pathophysiological role of mitochondria in the pathogenesis of type 2 diabetes will be discussed.
Collapse
Affiliation(s)
- Lisa Kappler
- Institute for Clinical Chemistry and Pathobiochemistry, Department for Diagnostic Laboratory Medicine, University Hospital Tuebingen, Tuebingen, Germany
| | - Laxmikanth Kollipara
- Leibniz-Institut für Analytische Wissenschaften - ISAS - e.V., Dortmund, Germany
| | - Rainer Lehmann
- Institute for Clinical Chemistry and Pathobiochemistry, Department for Diagnostic Laboratory Medicine, University Hospital Tuebingen, Tuebingen, Germany.,Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Centre Munich at the University of Tuebingen, Tuebingen, Germany.,German Center for Diabetes Research (DZD e.V.), Tuebingen, Germany
| | - Albert Sickmann
- Leibniz-Institut für Analytische Wissenschaften - ISAS - e.V., Dortmund, Germany. .,Medical Proteome Centre, Ruhr Universität Bochum, Bochum, Germany. .,Department of Chemistry, College of Physical Sciences, University of Aberdeen, Aberdeen, UK.
| |
Collapse
|
10
|
Lund J, Helle SA, Li Y, Løvsletten NG, Stadheim HK, Jensen J, Kase ET, Thoresen GH, Rustan AC. Higher lipid turnover and oxidation in cultured human myotubes from athletic versus sedentary young male subjects. Sci Rep 2018; 8:17549. [PMID: 30510272 PMCID: PMC6277406 DOI: 10.1038/s41598-018-35715-7] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/27/2018] [Accepted: 11/07/2018] [Indexed: 12/19/2022] Open
Abstract
In this study we compared fatty acid (FA) metabolism in myotubes established from athletic and sedentary young subjects. Six healthy sedentary (maximal oxygen uptake (VO2max) ≤ 46 ml/kg/min) and six healthy athletic (VO2max > 60 ml/kg/min) young men were included. Myoblasts were cultured and differentiated to myotubes from satellite cells isolated from biopsy of musculus vastus lateralis. FA metabolism was studied in myotubes using [14C]oleic acid. Lipid distribution was assessed by thin layer chromatography, and FA accumulation, lipolysis and re-esterification were measured by scintillation proximity assay. Gene and protein expressions were studied. Myotubes from athletic subjects showed lower FA accumulation, lower incorporation of FA into total lipids, triacylglycerol (TAG), diacylglycerol and cholesteryl ester, higher TAG-related lipolysis and re-esterification, and higher complete oxidation and incomplete β-oxidation of FA compared to myotubes from sedentary subjects. mRNA expression of the mitochondrial electron transport chain complex III gene UQCRB was higher in cells from athletic compared to sedentary. Myotubes established from athletic subjects have higher lipid turnover and oxidation compared to myotubes from sedentary subjects. Our findings suggest that cultured myotubes retain some of the phenotypic traits of their donors.
Collapse
Affiliation(s)
- Jenny Lund
- Department of Pharmaceutical Biosciences, School of Pharmacy, University of Oslo, Oslo, Norway.
| | - Siw A Helle
- Department of Pharmaceutical Biosciences, School of Pharmacy, University of Oslo, Oslo, Norway
| | - Yuchuan Li
- Department of Nutrition, Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway
| | - Nils G Løvsletten
- Department of Pharmaceutical Biosciences, School of Pharmacy, University of Oslo, Oslo, Norway
| | - Hans K Stadheim
- Department of Physical Performance, Norwegian School of Sport Sciences, Oslo, Norway
| | - Jørgen Jensen
- Department of Physical Performance, Norwegian School of Sport Sciences, Oslo, Norway
| | - Eili T Kase
- Department of Pharmaceutical Biosciences, School of Pharmacy, University of Oslo, Oslo, Norway
| | - G Hege Thoresen
- Department of Pharmaceutical Biosciences, School of Pharmacy, University of Oslo, Oslo, Norway.,Department of Pharmacology, Institute of Clinical Medicine, University of Oslo, Oslo, Norway
| | - Arild C Rustan
- Department of Pharmaceutical Biosciences, School of Pharmacy, University of Oslo, Oslo, Norway
| |
Collapse
|
11
|
Broskey NT, Obanda DN, Burton JH, Cefalu WT, Ravussin E. Skeletal muscle ceramides and daily fat oxidation in obesity and diabetes. Metabolism 2018; 82:118-123. [PMID: 29307520 PMCID: PMC5930033 DOI: 10.1016/j.metabol.2017.12.012] [Citation(s) in RCA: 26] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/21/2017] [Revised: 11/15/2017] [Accepted: 12/27/2017] [Indexed: 11/18/2022]
Abstract
BACKGROUND/OBJECTIVES Ectopic accumulation of lipids in skeletal muscle and the formation of deleterious lipid intermediates is thought to contribute to the development of insulin resistance and type 2 diabetes mellitus (T2DM). Similarly, impaired fat oxidation (metabolic inflexibility) are predictors of weight gain and the development of T2DM; however, no study has investigated the relation between muscle ceramide accumulation and 24-hour macronutrient oxidation. The purpose of this study was to retrospectively explore the relationships between whole body fat oxidation and skeletal muscle ceramide accumulation in obese non-diabetic individuals (ND) and in people with obesity and T2DM. METHODS Daily substrate oxidation was measured in a respiratory chamber and skeletal muscle ceramides were measured using liquid chromatographyelectrospray ionization tandem-mass spectrometry. RESULTS After adjusting for sex, age, and BMI, no differences existed between the groups for fat oxidation or 24-h RQ. However, ceramides C18:1, C:20, C22, C24 and C24:1 were significantly higher in people with T2DM compared to ND whereas no differences existed for C16 and C18. Despite low amounts of muscle ceramides, fat oxidation rates were positively associated with ceramide species concentration in ND only. Our data suggests that ceramides do not interfere with whole-body fat oxidation in ND individuals whereas a persistent lipid oversupply results in excessive ceramide muscle accumulation in people with T2DM.
Collapse
Affiliation(s)
- Nicholas T Broskey
- Pennington Biomedical Research Center, Baton Rouge, LA 70808, United States
| | - Diana N Obanda
- Pennington Biomedical Research Center, Baton Rouge, LA 70808, United States
| | - Jeffrey H Burton
- Pennington Biomedical Research Center, Baton Rouge, LA 70808, United States
| | - William T Cefalu
- Pennington Biomedical Research Center, Baton Rouge, LA 70808, United States
| | - Eric Ravussin
- Pennington Biomedical Research Center, Baton Rouge, LA 70808, United States.
| |
Collapse
|
12
|
Covington JD, Johannsen DL, Coen PM, Burk DH, Obanda DN, Ebenezer PJ, Tam CS, Goodpaster BH, Ravussin E, Bajpeyi S. Intramyocellular Lipid Droplet Size Rather Than Total Lipid Content is Related to Insulin Sensitivity After 8 Weeks of Overfeeding. Obesity (Silver Spring) 2017; 25:2079-2087. [PMID: 29071793 PMCID: PMC5705570 DOI: 10.1002/oby.21980] [Citation(s) in RCA: 17] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/06/2017] [Revised: 07/05/2017] [Accepted: 07/16/2017] [Indexed: 12/31/2022]
Abstract
OBJECTIVE Intramyocellular lipid (IMCL) is inversely related to insulin sensitivity in sedentary populations, yet no prospective studies in humans have examined IMCL accumulation with overfeeding. METHODS Twenty-nine males were overfed a high-fat diet (140% caloric intake, 44% from fat) for 8 weeks. Measures of IMCL, whole-body fat oxidation from a 24-hour metabolic chamber, muscle protein extracts, and muscle ceramide measures were obtained before and after the intervention. RESULTS Eight weeks of overfeeding did not increase overall IMCL. The content of smaller lipid droplets peripherally located in the myofiber decreased, while increases in larger droplets correlated inversely with glucose disposal rate. Overfeeding resulted in inhibition of Akt activity, which correlated with the reductions in smaller, peripherally located lipid droplets and drastic increases in ceramide content. Additionally, peripherally located lipid droplets were associated with more efficient lipid oxidation. Finally, participants who maintained a greater number of smaller, peripherally located lipid droplets displayed a better resistance to weight gain with overfeeding. CONCLUSIONS These results show that lipid droplet size and location rather than mere IMCL content are important to understanding insulin sensitivity.
Collapse
Affiliation(s)
- Jeffrey D. Covington
- Pennington Biomedical Research Center, Laboratory of Skeletal Muscle Physiology, 6400 Perkins Road, Baton Rouge, LA 70808
- Louisiana State University Health Sciences Center, School of Medicine, 433 Bolivar St, New Orleans, LA 70112
| | - Darcy L. Johannsen
- Pennington Biomedical Research Center, Laboratory of Skeletal Muscle Physiology, 6400 Perkins Road, Baton Rouge, LA 70808
| | - Paul M. Coen
- Translational Research Institute for Metabolism and Diabetes Florida Hospital • Sanford-Burnham Medical Research Institute, 301 East Princeton Street, Orlando, FL 32804
| | - David H. Burk
- Pennington Biomedical Research Center, Laboratory of Skeletal Muscle Physiology, 6400 Perkins Road, Baton Rouge, LA 70808
| | - Diana N. Obanda
- Pennington Biomedical Research Center, Laboratory of Skeletal Muscle Physiology, 6400 Perkins Road, Baton Rouge, LA 70808
| | - Philip J. Ebenezer
- Pennington Biomedical Research Center, Laboratory of Skeletal Muscle Physiology, 6400 Perkins Road, Baton Rouge, LA 70808
| | - Charmaine S. Tam
- The Charles Perkins Centre and The School of Biological Sciences, University of Sydney, NSW, Australia
| | - Bret H. Goodpaster
- Translational Research Institute for Metabolism and Diabetes Florida Hospital • Sanford-Burnham Medical Research Institute, 301 East Princeton Street, Orlando, FL 32804
| | - Eric Ravussin
- Pennington Biomedical Research Center, Laboratory of Skeletal Muscle Physiology, 6400 Perkins Road, Baton Rouge, LA 70808
| | - Sudip Bajpeyi
- Pennington Biomedical Research Center, Laboratory of Skeletal Muscle Physiology, 6400 Perkins Road, Baton Rouge, LA 70808
- Universtiy of Texas at El Paso, Department of Kinesiology, 500 University Ave, El Paso, TX, 79968
| |
Collapse
|
13
|
Kuzmenko DI, Klimentyeva TK. Role of Ceramide in Apoptosis and Development of Insulin Resistance. BIOCHEMISTRY (MOSCOW) 2017; 81:913-27. [PMID: 27682164 DOI: 10.1134/s0006297916090017] [Citation(s) in RCA: 26] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/27/2022]
Abstract
This review presents data on the functional biochemistry of ceramide, one of the key sphingolipids with properties of a secondary messenger. Molecular mechanisms of the involvement of ceramide in apoptosis in pancreatic β-cells and its role in the formation of insulin resistance in pathogenesis of type 2 diabetes are reviewed. One of the main predispositions for the development of insulin resistance and diabetes is obesity, which is associated with ectopic fat deposition and significant increase in intracellular concentrations of cytotoxic ceramides. A possible approach to the restoration of tissue sensitivity to insulin in type 2 diabetes based on selective reduction of the content of cytotoxic ceramides is discussed.
Collapse
Affiliation(s)
- D I Kuzmenko
- Siberian State Medical University, Ministry of Healthcare of the Russian Federation, Tomsk, 634050, Russia.
| | | |
Collapse
|
14
|
Fucho R, Casals N, Serra D, Herrero L. Ceramides and mitochondrial fatty acid oxidation in obesity. FASEB J 2016; 31:1263-1272. [PMID: 28003342 DOI: 10.1096/fj.201601156r] [Citation(s) in RCA: 76] [Impact Index Per Article: 9.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/19/2016] [Accepted: 12/06/2016] [Indexed: 12/12/2022]
Abstract
Obesity is an epidemic, complex disease that is characterized by increased glucose, lipids, and low-grade inflammation in the circulation, among other factors. It creates the perfect scenario for the production of ceramide, the building block of the sphingolipid family of lipids, which is involved in metabolic disorders such as obesity, diabetes, and cardiovascular disease. In addition, obesity causes a decrease in fatty acid oxidation (FAO), which contributes to lipid accumulation within the cells, conferring more susceptibility to cell dysfunction. C16:0 ceramide, a specific ceramide species, has been identified recently as the principal mediator of obesity-derived insulin resistance, impaired fatty acid oxidation, and hepatic steatosis. In this review, we have sought to cover the importance of the ceramide species and their metabolism, the main ceramide signaling pathways in obesity, and the link between C16:0 ceramide, FAO, and obesity.-Fucho, R., Casals, N., Serra, D., Herrero, L. Ceramides and mitochondrial fatty acid oxidation in obesity.
Collapse
Affiliation(s)
- Raquel Fucho
- Department of Biochemistry and Physiology, School of Pharmacy, Institut de Biomedicina, Universitat de Barcelona, Barcelona, Spain
| | - Núria Casals
- Basic Sciences Department, Faculty of Medicine and Health Sciences, Universitat Internacional de Catalunya, Barcelona, Spain; and.,Centro de Investigación Biomédica en Red de Fisiopatología de la Obesidad y la Nutrición, Instituto de Salud Carlos III, Madrid, Spain
| | - Dolors Serra
- Department of Biochemistry and Physiology, School of Pharmacy, Institut de Biomedicina, Universitat de Barcelona, Barcelona, Spain; .,Centro de Investigación Biomédica en Red de Fisiopatología de la Obesidad y la Nutrición, Instituto de Salud Carlos III, Madrid, Spain
| | - Laura Herrero
- Department of Biochemistry and Physiology, School of Pharmacy, Institut de Biomedicina, Universitat de Barcelona, Barcelona, Spain; .,Centro de Investigación Biomédica en Red de Fisiopatología de la Obesidad y la Nutrición, Instituto de Salud Carlos III, Madrid, Spain
| |
Collapse
|
15
|
Kwon OS, Nelson DS, Barrows KM, O'Connell RM, Drummond MJ. Intramyocellular ceramides and skeletal muscle mitochondrial respiration are partially regulated by Toll-like receptor 4 during hindlimb unloading. Am J Physiol Regul Integr Comp Physiol 2016; 311:R879-R887. [PMID: 27581814 DOI: 10.1152/ajpregu.00253.2016] [Citation(s) in RCA: 19] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/10/2016] [Accepted: 08/22/2016] [Indexed: 12/22/2022]
Abstract
Physical inactivity and disuse result in skeletal muscle metabolic disruption, including insulin resistance and mitochondrial dysfunction. The role of the Toll-like receptor 4 (TLR4) signaling pathway in contributing to metabolic decline with muscle disuse is unknown. Therefore, our goal was to determine whether TLR4 is an underlying mechanism of insulin resistance, mitochondrial dysfunction, and skeletal muscle ceramide accumulation following muscle disuse in mice. To address this hypothesis, we subjected (n = 6-8/group) male WT and TLR4-/- mice to 2 wk of hindlimb unloading (HU), while a second group of mice served as ambulatory wild-type controls (WT CON, TLR4-/- CON). Mice were assessed for insulin resistance [homeostatic model assessment-insulin resistance (HOMA-IR), glucose tolerance], and hindlimb muscles (soleus and gastrocnemius) were used to assess muscle sphingolipid abundance, mitochondrial respiration [respiratory control ratio (RCR)], and NF-κB signaling. The primary finding was that HU resulted in insulin resistance, increased total ceramides, specifically Cer18:0 and Cer20:0, and decreased skeletal muscle mitochondrial respiration. Importantly, TLR4-/- HU mice were protected from insulin resistance and altered NF-κB signaling and were partly resistant to muscle atrophy, ceramide accumulation, and decreased RCR. Skeletal muscle ceramides and RCR were correlated with insulin resistance. We conclude that TLR4 is an upstream regulator of insulin sensitivity, while partly upregulating muscle ceramides and worsening mitochondrial respiration during 2 wk of HU.
Collapse
Affiliation(s)
- Oh Sung Kwon
- Geriatric Research, Education, and Clinical Center, George E. Whalen Veterans Affairs Medical Center, Salt Lake City, Utah
| | - Daniel S Nelson
- Department of Nutrition and Integrative Physiology, University of Utah, Salt Lake City, Utah
| | | | - Ryan M O'Connell
- Department of Pathology, University of Utah, Salt Lake City, Utah; and
| | - Micah J Drummond
- Department of Nutrition and Integrative Physiology, University of Utah, Salt Lake City, Utah; .,Department of Physical Therapy, University of Utah, Salt Lake City, Utah.,Department of Pathology, University of Utah, Salt Lake City, Utah; and.,Division of Diabetes, Metabolism and Endocrinology, University of Utah, Salt Lake City, Utah
| |
Collapse
|
16
|
Covington JD, Myland CK, Rustan AC, Ravussin E, Smith SR, Bajpeyi S. Effect of serial cell passaging in the retention of fiber type and mitochondrial content in primary human myotubes. Obesity (Silver Spring) 2015; 23:2414-20. [PMID: 26538189 PMCID: PMC4701579 DOI: 10.1002/oby.21192] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/12/2014] [Revised: 04/30/2015] [Accepted: 05/18/2015] [Indexed: 01/05/2023]
Abstract
OBJECTIVE The purpose of the study was to determine the effects of passaging on retention of donor phenotypic characteristics in primary human myotubes. METHODS Primary muscle cultures and serial passaged myotubes from physically active, sedentary lean, and individuals with type 2 diabetes were established. Maximal ATP synthesis capacity (ATPmax) and resting ATP flux (ATPase) in vivo were measured by (31) P magnetic resonance spectroscopy, type-I fibers and intramyocelluar lipid (IMCL) in vastus lateralis tissue were determined using immunohistochemistry techniques, and oxidative phosphorylation complexes (OXPHOS) were measured by Western immunoblotting. Similar in vitro measures for lipid and type-I fibers were made in myotubes, along with mitochondrial content measured by MitoTracker. RESULTS Passage 4 and 5 measures for myotubes correlated positively with in vivo measurements for percent type-I fibers (P4: R(2) = 0.39, p = 0.02; P5: R(2) = 0.48, p = 0.01), ATPmax (P4: R(2) = 0.30, p = 0.03; P5: R(2) = 0.22, p = 0.05), and OXPHOS (P4: R(2) = 0.44, p = 0.04; P5: R(2) = 0.59, p = 0.006). No correlations were observed for IMCL. However, passage 4 measures for myotubes correlated with passage 5 measures for percent type-I fibers (R(2) = 0.49, p = 0.01), IMCL (R(2) = 0.80, p < 0.001), and mitochondrial content (R(2) = 0.26, p = 0.03). CONCLUSIONS Myotubes through the first two passages following immunopurification (referred to as passage 4 and 5) reflect the mitochondrial and type-I fiber content in vivo phenotype of the donor.
Collapse
Affiliation(s)
- Jeffrey D. Covington
- Pennington Biomedical Research Center, Laboratory of Skeletal Muscle Physiology, 6400 Perkins Road, Baton Rouge, LA 70808
- Louisiana State University Health Sciences Center, School of Medicine, 433 Bolivar St, New Orleans, LA 70112
| | - Cassandra K. Myland
- Pennington Biomedical Research Center, Laboratory of Skeletal Muscle Physiology, 6400 Perkins Road, Baton Rouge, LA 70808
| | - Arild C. Rustan
- Department of Pharmaceutical Biosciences, School of Pharmacy, University of Oslo, Oslo, Norway
| | - Eric Ravussin
- Pennington Biomedical Research Center, Laboratory of Skeletal Muscle Physiology, 6400 Perkins Road, Baton Rouge, LA 70808
| | - Steven R. Smith
- Translational Research Institute for Metabolism and Diabetes, Florida Hospital, Sanford-Burnham Medical Research Institute, 2566 Lee Rd, Winter Park, FL 32789
| | - Sudip Bajpeyi
- Pennington Biomedical Research Center, Laboratory of Skeletal Muscle Physiology, 6400 Perkins Road, Baton Rouge, LA 70808
- Universtiy of Texas at El Paso, Department of Kinesiology, 500 University Ave, El Paso, TX, 79968
| |
Collapse
|
17
|
Covington JD, Noland RC, Hebert RC, Masinter BS, Smith SR, Rustan AC, Ravussin E, Bajpeyi S. Perilipin 3 Differentially Regulates Skeletal Muscle Lipid Oxidation in Active, Sedentary, and Type 2 Diabetic Males. J Clin Endocrinol Metab 2015; 100:3683-92. [PMID: 26171795 PMCID: PMC4596049 DOI: 10.1210/jc.2014-4125] [Citation(s) in RCA: 34] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/03/2023]
Abstract
CONTEXT The role of perilipin 3 (PLIN3) on lipid oxidation is not fully understood. OBJECTIVE We aimed to 1) determine whether skeletal muscle PLIN3 protein content is associated with lipid oxidation in humans, 2) understand the role of PLIN3 in lipid oxidation by knocking down PLIN3 protein content in primary human myotubes, and 3) compare PLIN3 content and its role in lipid oxidation in human primary skeletal muscle cultures established from sedentary, healthy lean (leans), type 2 diabetic (T2D), and physically active donors. DESIGN, PARTICIPANTS, AND INTERVENTION This was a clinical investigation of 29 healthy, normoglycemic males and a cross-sectional study using primary human myotubes from five leans, four T2D, and four active donors. Energy expenditure, whole-body lipid oxidation, PLIN3 protein content in skeletal muscle tissue, and ex vivo muscle palmitate oxidation were measured. Myotubes underwent lipolytic stimulation (palmitate, forskolin, inomycin [PFI] cocktail), treatment with brefeldin A (BFA), and knockdown of PLIN3 using siRNA. SETTING Experiments were performed in a Biomedical Research Institute. MAIN OUTCOME MEASURES Protein content, 24-hour respiratory quotient (RQ), and ex vivo/in vitro lipid oxidations. RESULTS PLIN3 protein content was associated with 24-h RQ (r = -0.44; P = .02) and skeletal muscle-specific ex vivo palmitate oxidation (r = 0.61; P = .02). PLIN3 knockdown showed drastic reductions in lipid oxidation in myotubes from leans. Lipolytic stimulation increased PLIN3 protein in cells from leans over T2Ds with little expression in active participants. Furthermore, treatment with BFA, known to inhibit coatomers that associate with PLIN3, reduced lipid oxidation in cells from lean and T2D, but not in active participants. CONCLUSIONS Differential expression of PLIN3 and BFA sensitivity may explain differential lipid oxidation efficiency in skeletal muscle among these cohorts.
Collapse
Affiliation(s)
- Jeffrey D Covington
- Pennington Biomedical Research Center (J.D.C., R.C.N., R.C.H., B.S.M., E.R., S.B.), Laboratory of Skeletal Muscle Physiology, Baton Rouge, Louisiana 70808; Louisiana State University Health Sciences Center (J.D.C.), School of Medicine, New Orleans, Louisiana 70112; Translational Research Institute for Metabolism and Diabetes (S.R.S.), Florida Hospital, Sanford-Burnham Medical Research Institute, Winter Park, Florida 32789; Department of Pharmaceutical Biosciences (A.C.R.), University of Oslo, Oslo, Norway; and Department of Kinesiology (S.B.), University of Texas-El Paso, El Paso, Texas 79968
| | - Robert C Noland
- Pennington Biomedical Research Center (J.D.C., R.C.N., R.C.H., B.S.M., E.R., S.B.), Laboratory of Skeletal Muscle Physiology, Baton Rouge, Louisiana 70808; Louisiana State University Health Sciences Center (J.D.C.), School of Medicine, New Orleans, Louisiana 70112; Translational Research Institute for Metabolism and Diabetes (S.R.S.), Florida Hospital, Sanford-Burnham Medical Research Institute, Winter Park, Florida 32789; Department of Pharmaceutical Biosciences (A.C.R.), University of Oslo, Oslo, Norway; and Department of Kinesiology (S.B.), University of Texas-El Paso, El Paso, Texas 79968
| | - R Caitlin Hebert
- Pennington Biomedical Research Center (J.D.C., R.C.N., R.C.H., B.S.M., E.R., S.B.), Laboratory of Skeletal Muscle Physiology, Baton Rouge, Louisiana 70808; Louisiana State University Health Sciences Center (J.D.C.), School of Medicine, New Orleans, Louisiana 70112; Translational Research Institute for Metabolism and Diabetes (S.R.S.), Florida Hospital, Sanford-Burnham Medical Research Institute, Winter Park, Florida 32789; Department of Pharmaceutical Biosciences (A.C.R.), University of Oslo, Oslo, Norway; and Department of Kinesiology (S.B.), University of Texas-El Paso, El Paso, Texas 79968
| | - Blaine S Masinter
- Pennington Biomedical Research Center (J.D.C., R.C.N., R.C.H., B.S.M., E.R., S.B.), Laboratory of Skeletal Muscle Physiology, Baton Rouge, Louisiana 70808; Louisiana State University Health Sciences Center (J.D.C.), School of Medicine, New Orleans, Louisiana 70112; Translational Research Institute for Metabolism and Diabetes (S.R.S.), Florida Hospital, Sanford-Burnham Medical Research Institute, Winter Park, Florida 32789; Department of Pharmaceutical Biosciences (A.C.R.), University of Oslo, Oslo, Norway; and Department of Kinesiology (S.B.), University of Texas-El Paso, El Paso, Texas 79968
| | - Steven R Smith
- Pennington Biomedical Research Center (J.D.C., R.C.N., R.C.H., B.S.M., E.R., S.B.), Laboratory of Skeletal Muscle Physiology, Baton Rouge, Louisiana 70808; Louisiana State University Health Sciences Center (J.D.C.), School of Medicine, New Orleans, Louisiana 70112; Translational Research Institute for Metabolism and Diabetes (S.R.S.), Florida Hospital, Sanford-Burnham Medical Research Institute, Winter Park, Florida 32789; Department of Pharmaceutical Biosciences (A.C.R.), University of Oslo, Oslo, Norway; and Department of Kinesiology (S.B.), University of Texas-El Paso, El Paso, Texas 79968
| | - Arild C Rustan
- Pennington Biomedical Research Center (J.D.C., R.C.N., R.C.H., B.S.M., E.R., S.B.), Laboratory of Skeletal Muscle Physiology, Baton Rouge, Louisiana 70808; Louisiana State University Health Sciences Center (J.D.C.), School of Medicine, New Orleans, Louisiana 70112; Translational Research Institute for Metabolism and Diabetes (S.R.S.), Florida Hospital, Sanford-Burnham Medical Research Institute, Winter Park, Florida 32789; Department of Pharmaceutical Biosciences (A.C.R.), University of Oslo, Oslo, Norway; and Department of Kinesiology (S.B.), University of Texas-El Paso, El Paso, Texas 79968
| | - Eric Ravussin
- Pennington Biomedical Research Center (J.D.C., R.C.N., R.C.H., B.S.M., E.R., S.B.), Laboratory of Skeletal Muscle Physiology, Baton Rouge, Louisiana 70808; Louisiana State University Health Sciences Center (J.D.C.), School of Medicine, New Orleans, Louisiana 70112; Translational Research Institute for Metabolism and Diabetes (S.R.S.), Florida Hospital, Sanford-Burnham Medical Research Institute, Winter Park, Florida 32789; Department of Pharmaceutical Biosciences (A.C.R.), University of Oslo, Oslo, Norway; and Department of Kinesiology (S.B.), University of Texas-El Paso, El Paso, Texas 79968
| | - Sudip Bajpeyi
- Pennington Biomedical Research Center (J.D.C., R.C.N., R.C.H., B.S.M., E.R., S.B.), Laboratory of Skeletal Muscle Physiology, Baton Rouge, Louisiana 70808; Louisiana State University Health Sciences Center (J.D.C.), School of Medicine, New Orleans, Louisiana 70112; Translational Research Institute for Metabolism and Diabetes (S.R.S.), Florida Hospital, Sanford-Burnham Medical Research Institute, Winter Park, Florida 32789; Department of Pharmaceutical Biosciences (A.C.R.), University of Oslo, Oslo, Norway; and Department of Kinesiology (S.B.), University of Texas-El Paso, El Paso, Texas 79968
| |
Collapse
|
18
|
Mahfouz R, Khoury R, Blachnio-Zabielska A, Turban S, Loiseau N, Lipina C, Stretton C, Bourron O, Ferré P, Foufelle F, Hundal HS, Hajduch E. Characterising the inhibitory actions of ceramide upon insulin signaling in different skeletal muscle cell models: a mechanistic insight. PLoS One 2014; 9:e101865. [PMID: 25058613 PMCID: PMC4109934 DOI: 10.1371/journal.pone.0101865] [Citation(s) in RCA: 41] [Impact Index Per Article: 4.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/21/2014] [Accepted: 06/12/2014] [Indexed: 12/31/2022] Open
Abstract
Ceramides are known to promote insulin resistance in a number of metabolically important tissues including skeletal muscle, the predominant site of insulin-stimulated glucose disposal. Depending on cell type, these lipid intermediates have been shown to inhibit protein kinase B (PKB/Akt), a key mediator of the metabolic actions of insulin, via two distinct pathways: one involving the action of atypical protein kinase C (aPKC) isoforms, and the second dependent on protein phosphatase-2A (PP2A). The main aim of this study was to explore the mechanisms by which ceramide inhibits PKB/Akt in three different skeletal muscle-derived cell culture models; rat L6 myotubes, mouse C2C12 myotubes and primary human skeletal muscle cells. Our findings indicate that the mechanism by which ceramide acts to repress PKB/Akt is related to the myocellular abundance of caveolin-enriched domains (CEM) present at the plasma membrane. Here, we show that ceramide-enriched-CEMs are markedly more abundant in L6 myotubes compared to C2C12 myotubes, consistent with their previously reported role in coordinating aPKC-directed repression of PKB/Akt in L6 muscle cells. In contrast, a PP2A-dependent pathway predominantly mediates ceramide-induced inhibition of PKB/Akt in C2C12 myotubes. In addition, we demonstrate for the first time that ceramide engages an aPKC-dependent pathway to suppress insulin-induced PKB/Akt activation in palmitate-treated cultured human muscle cells as well as in muscle cells from diabetic patients. Collectively, this work identifies key mechanistic differences, which may be linked to variations in plasma membrane composition, underlying the insulin-desensitising effects of ceramide in different skeletal muscle cell models that are extensively used in signal transduction and metabolic studies.
Collapse
Affiliation(s)
- Rana Mahfouz
- INSERM, UMR-S 1138, Centre de Recherche des Cordeliers, Paris, France
- Université Pierre et Marie Curie – Paris 6, UMR-S 1138, Paris, France
- Université Paris Descartes, UMR-S 1138, Paris, France
| | - Rhéa Khoury
- INSERM, UMR-S 1138, Centre de Recherche des Cordeliers, Paris, France
- Université Pierre et Marie Curie – Paris 6, UMR-S 1138, Paris, France
- Université Paris Descartes, UMR-S 1138, Paris, France
| | | | - Sophie Turban
- Division of Cell Signalling and Immunology, College of Life Sciences, University of Dundee, Dundee, United Kingdom
| | - Nicolas Loiseau
- INRA, UMR1331 Toxalim, Research Centre in Food Toxicology, Toulouse, France
| | - Christopher Lipina
- Division of Cell Signalling and Immunology, College of Life Sciences, University of Dundee, Dundee, United Kingdom
| | - Clare Stretton
- Division of Cell Signalling and Immunology, College of Life Sciences, University of Dundee, Dundee, United Kingdom
| | - Olivier Bourron
- INSERM, UMR-S 1138, Centre de Recherche des Cordeliers, Paris, France
- Université Pierre et Marie Curie – Paris 6, UMR-S 1138, Paris, France
- Université Paris Descartes, UMR-S 1138, Paris, France
- Département de Diabétologie et Maladies métaboliques, AP-HP, Hôpital Pitié-Salpêtrière, Paris, France
| | - Pascal Ferré
- INSERM, UMR-S 1138, Centre de Recherche des Cordeliers, Paris, France
- Université Pierre et Marie Curie – Paris 6, UMR-S 1138, Paris, France
- Université Paris Descartes, UMR-S 1138, Paris, France
| | - Fabienne Foufelle
- INSERM, UMR-S 1138, Centre de Recherche des Cordeliers, Paris, France
- Université Pierre et Marie Curie – Paris 6, UMR-S 1138, Paris, France
- Université Paris Descartes, UMR-S 1138, Paris, France
| | - Harinder S. Hundal
- Division of Cell Signalling and Immunology, College of Life Sciences, University of Dundee, Dundee, United Kingdom
| | - Eric Hajduch
- INSERM, UMR-S 1138, Centre de Recherche des Cordeliers, Paris, France
- Université Pierre et Marie Curie – Paris 6, UMR-S 1138, Paris, France
- Université Paris Descartes, UMR-S 1138, Paris, France
| |
Collapse
|
19
|
Hage Hassan R, Bourron O, Hajduch E. Defect of insulin signal in peripheral tissues: Important role of ceramide. World J Diabetes 2014; 5:244-257. [PMID: 24936246 PMCID: PMC4058729 DOI: 10.4239/wjd.v5.i3.244] [Citation(s) in RCA: 57] [Impact Index Per Article: 5.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/12/2013] [Revised: 01/29/2014] [Accepted: 05/08/2014] [Indexed: 02/05/2023] Open
Abstract
In healthy people, balance between glucose production and its utilization is precisely controlled. When circulating glucose reaches a critical threshold level, pancreatic β cells secrete insulin that has two major actions: to lower circulating glucose levels by facilitating its uptake mainly into skeletal muscle while inhibiting its production by the liver. Interestingly, dietary triglycerides are the main source of fatty acids to fulfill energy needs of oxidative tissues. Normally, the unconsumed fraction of excess of fatty acids is stored in lipid droplets that are localized in adipocytes to provide energy during fasting periods. Thus, adipose tissue acts as a trap for fatty acid excess liberated from plasma triglycerides. When the buffering action of adipose tissue to store fatty acids is impaired, fatty acids that build up in other tissues are metabolized as sphingolipid derivatives such as ceramides. Several studies suggest that ceramides are among the most active lipid second messengers to inhibit the insulin signaling pathway and this review describes the major role played by ceramide accumulation in the development of insulin resistance of peripherals tissues through the targeting of specific proteins of the insulin signaling pathway.
Collapse
|
20
|
Taylor EM, Jones AD, Henagan TM. A Review of Mitochondrial-derived Fatty Acids in Epigenetic Regulation of Obesity and Type 2 Diabetes. ACTA ACUST UNITED AC 2014; 2:1-4. [PMID: 25364776 DOI: 10.15226/jnhfs.2014.00127] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/16/2022]
Abstract
Type 2 diabetes, the leading metabolic disease, is characterized by insulin resistance and is associated with obesity. The onset of type 2 diabetes is largely due to environmental inputs, such as high dietary fat content and decreased levels of exercise. Insulin resistance resulting from high fat diet is associated with skeletal muscle mitochondrial dysfunction, leading to alterations in lipid accumulation and specific species of intracellular fatty acids; whereas, exercise training augments insulin resistance while improving skeletal muscle mitochondrial function and producing beneficial fatty acid profiles. Additionally, high fat diets and exercise alter epigenetic modifications, including DNA methylation and histone acetylation, to produce differences in metabolic gene expression that are associated with insulin resistance and sensitivity, respectively. Recent evidence suggests that short chain fatty acids that act as histone deacetylase inhibitors prevent and ameliorate obesity and insulin resistance. Here, we discuss the potential of mitochondrial-derived fatty acids, especially short chain fatty acids, to epigenetically regulate obesity and type 2 diabetes.
Collapse
Affiliation(s)
- Erin M Taylor
- Department of Nutrition Science, Purdue University, West Lafayette, IN, USA
| | - Aarin D Jones
- Department of Nutrition Science, Purdue University, West Lafayette, IN, USA
| | - Tara M Henagan
- Department of Nutrition Science, Purdue University, West Lafayette, IN, USA
| |
Collapse
|